Joe Putnam
Faculty Member
Last active: 3/27/2014

  1. Inflammatory gene polymorphisms influence risk of postoperative morbidity after lung resection. Shaw AD, Vaporciyan AA, Wu X, King TM, Spitz MR, Putnam JB, Dickey BF (2005) Ann Thorac Surg 79(5): 1704-10
    › Primary publication · 15854959 (PubMed)
  2. [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer. Sasaki R, Komaki R, Macapinlac H, Erasmus J, Allen P, Forster K, Putnam JB, Herbst RS, Moran CA, Podoloff DA, Roth JA, Cox JD (2005) J Clin Oncol 23(6): 1136-43
    › Primary publication · 15718309 (PubMed)
  3. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer. Swisher SG, Maish M, Erasmus JJ, Correa AM, Ajani JA, Bresalier R, Komaki R, Macapinlac H, Munden RF, Putnam JB, Rice D, Smythe WR, Vaporciyan AA, Walsh GL, Wu TT, Roth JA (2004) Ann Thorac Surg 78(4): 1152-60; discussion 1152-60
    › Primary publication · 15464463 (PubMed)
  4. The potential role of aprotinin in the perioperative management of malignant tumors. Vaporciyan AA, Putnam JB, Smythe WR (2004) J Am Coll Surg 198(2): 266-78
    › Primary publication · 14759785 (PubMed)
  5. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer. Onn A, Correa AM, Gilcrease M, Isobe T, Massarelli E, Bucana CD, O'Reilly MS, Hong WK, Fidler IJ, Putnam JB, Herbst RS (2004) Clin Cancer Res 10(1 Pt 1): 136-43
    › Primary publication · 14734462 (PubMed)
  6. Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients. Vaporciyan AA, Correa AM, Rice DC, Roth JA, Smythe WR, Swisher SG, Walsh GL, Putnam JB (2004) J Thorac Cardiovasc Surg 127(3): 779-86
    › Primary publication · 15001907 (PubMed)
  7. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA (2004) Cancer 100(11): 2347-54
    › Primary publication · 15160337 (PubMed)
  8. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report. Kim ES, Putnam JB, Komaki R, Walsh GL, Ro JY, Shin HJ, Truong M, Moon H, Swisher SG, Fossella FV, Khuri FR, Hong WK, Shin DM (2004) Lung Cancer 44(3): 369-79
    › Primary publication · 15140551 (PubMed)
  9. Mentoring clinical trials in thoracic and cardiovascular surgery: a new role for the Society of Thoracic Surgeons. Gaissert HA, Casale AS, Creswell LL, Ferguson TB, Fullerton DA, Kernstine KH, McMullan DM, Ring WS, Putnam JB, Society of Thoracic Surgeons Workforce on Clinical Trials (2004) Ann Thorac Surg 77(5): 1874-5
    › Primary publication · 15111218 (PubMed)
  10. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R (2004) Int J Radiat Oncol Biol Phys 60(2): 427-36
    › Primary publication · 15380576 (PubMed)